SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 14th, 2022 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September 9, 2022, between InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 14th, 2022 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of September 9, 2022, between InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
PRE-FUNDED COMMON SHARES PURCHASE WARRANT INMED PHARMACEUTICALS INC.InMed Pharmaceuticals Inc. • September 14th, 2022 • Pharmaceutical preparations • New York
THIS PRE-FUNDED COMMON SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to __________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Shares. The purchase price of one share of Common Shares under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
PREFERRED INVESTMENT OPTION INMED PHARMACEUTICALS INC.InMed Pharmaceuticals Inc. • September 14th, 2022 • Pharmaceutical preparations • New York
THIS PREFERRED INVESTMENT OPTION (the “Preferred Investment Option”) certifies that, for value received, _______________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) ___________2 (the “Termination Date”) but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to ________ shares (as subject to adjustment hereunder, the “Preferred Investment Option Shares”) of Common Shares. The purchase price of one share of Common Shares under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2(b).
